acc1551 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Sarcoma |
SA-4 |
Vemurafenib |
Associated |
4.0 |
29570692
|
acc1552 |
EGFR |
phosphorylation |
unclear |
human |
Ovarian Cancer |
SK-OV-3 |
Y-142 |
Associated |
4.0 |
23251664
|
acc1553 |
ERBB4 |
phosphorylation |
unclear |
human |
Ovarian Cancer |
SK-OV-3 |
Y-142 |
Associated |
4.0 |
23251664
|
acc1554 |
ERK1 |
phosphorylation |
Thr202 |
mouse |
Myeloma |
MOPC-31C |
YM529 + ONO-5920 |
Associated |
4.0 |
17979996
|
acc1555 |
ERK1 |
phosphorylation |
Tyr204 |
mouse |
Myeloma |
MOPC-31C |
YM529 + ONO-5920 |
Associated |
4.0 |
17979996
|
acc1556 |
ERK2 |
phosphorylation |
Thr185 |
mouse |
Myeloma |
MOPC-31C |
YM529 + ONO-5920 |
Associated |
4.0 |
17979996
|
acc1557 |
ERK2 |
phosphorylation |
Tyr187 |
mouse |
Myeloma |
MOPC-31C |
YM529 + ONO-5920 |
Associated |
4.0 |
17979996
|
acc1558 |
Akt |
phosphorylation |
Ser473 |
mouse |
Myeloma |
MOPC-31C |
YM529 + ONO-5920 |
Associated |
4.0 |
17979996
|
acc1559 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Esophageal Cancer |
ESO26-PAC-r (paclitaxel-resistant) |
Paclitaxel |
Impairing |
5.0 |
32579788
|
acc1560 |
70S6K |
phosphorylation |
Thr389 |
human |
Esophageal Cancer |
ESO26-PAC-r (paclitaxel-resistant) |
Paclitaxel |
Impairing |
5.0 |
32579788
|
acc1561 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Esophageal Cancer |
KYAE-1-PAC-r (paclitaxel-resistant) |
Paclitaxel |
Impairing |
5.0 |
32579788
|
acc1562 |
70S6K |
phosphorylation |
Thr389 |
human |
Esophageal Cancer |
KYAE-1-PAC-r (paclitaxel-resistant) |
Paclitaxel |
Impairing |
5.0 |
32579788
|
acc1563 |
AKT |
phosphorylation |
Thr308 |
human |
Merkel Cell Carcinoma |
MGH-mcc1 |
ZST474 |
Associated |
4.0 |
22261808
|
acc1564 |
AKT |
phosphorylation |
Ser473 |
human |
Merkel Cell Carcinoma |
MGH-mcc1 |
ZST474 |
Associated |
4.0 |
22261808
|
acc1565 |
AKT |
phosphorylation |
Thr308 |
human |
Merkel Cell Carcinoma |
MGH-mcc1 |
NVP-BEZ235 |
Associated |
4.0 |
22261808
|
acc1566 |
AKT |
phosphorylation |
Ser473 |
human |
Merkel Cell Carcinoma |
MGH-mcc1 |
NVP-BEZ235 |
Associated |
4.0 |
22261808
|
acc1567 |
cullin |
neddylation |
unclear |
human |
Breast Cancer |
MCF7 |
MLN4924 |
Associated |
4.0 |
23151137
|
acc1568 |
cullin |
neddylation |
unclear |
human |
Cervical Cancer |
EGFP-LC3+ HeLa |
MLN4924 |
Associated |
4.0 |
23151137
|
acc1569 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MDA-MB-231 |
Paclitaxel |
Impairing |
5.0 |
21518725
|
acc1570 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MDA-MB-435 |
Paclitaxel |
Impairing |
5.0 |
21518725
|
acc1571 |
JAK2 |
phosphorylation |
Tyr1007 |
human |
Breast Cancer |
MDA-MB-231 |
Paclitaxel |
Impairing |
5.0 |
21518725
|
acc1572 |
JAK2 |
phosphorylation |
Tyr1007 |
human |
Breast Cancer |
MDA-MB-435 |
Paclitaxel |
Impairing |
5.0 |
21518725
|
acc1573 |
JAK2 |
phosphorylation |
Tyr1008 |
human |
Breast Cancer |
MDA-MB-231 |
Paclitaxel |
Impairing |
5.0 |
21518725
|
acc1574 |
JAK2 |
phosphorylation |
Tyr1008 |
human |
Breast Cancer |
MDA-MB-435 |
Paclitaxel |
Impairing |
5.0 |
21518725
|
acc1575 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
CN-CPT |
Associated |
4.0 |
27301177
|
acc1576 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
PC3 |
CN-CPT |
Associated |
4.0 |
27301177
|
acc1577 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Myeloma |
U266 |
LLL12 |
Associated |
4.0 |
21520044
|
acc1578 |
AKT |
phosphorylation |
Ser473 |
human |
Esophageal Cancer |
|
Cisplatin |
Impairing |
5.0 |
36525138
|
acc1579 |
YB1 |
phosphorylation |
Ser102 |
human |
Hepatocellular Carcinoma |
HuH-7R(sorafenib-resistant) |
Sorafenib |
Associated |
4.0 |
33379356
|
acc1580 |
AMPK |
phosphorylation |
Thr172 |
human |
Leukemia |
|
acadesine |
Associated |
4.0 |
12522004
|
acc1581 |
AMPK |
phosphorylation |
Thr183 |
human |
Leukemia |
|
acadesine |
Associated |
4.0 |
12522004
|
acc1582 |
ERalpha |
phosphorylation |
Ser118 |
human |
Breast Cancer |
MCF7 |
PGE2 |
Associated |
4.0 |
20093341
|
acc1583 |
ERalpha |
phosphorylation |
Ser167 |
human |
Breast Cancer |
MCF7 |
PGE2 |
Associated |
4.0 |
20093341
|
acc1584 |
ERalpha |
phosphorylation |
Ser305 |
human |
Breast Cancer |
MCF7 |
PGE2 |
Associated |
4.0 |
20093341
|
acc1585 |
CREB |
phosphorylation |
Ser133 |
human |
Breast Cancer |
MCF7 |
Radiotherapy |
Associated |
4.0 |
26655813
|
acc1586 |
Caveolin-1 |
phosphorylation |
Tyr14 |
human |
Gastric Cancer |
SGC7901/Adr |
adriamycin(Dox) |
Impairing |
5.0 |
25788263
|
acc1587 |
Caveolin-1 |
phosphorylation |
Tyr14 |
human |
Breast Cancer |
MCF7/Adr |
adriamycin(Dox) |
Impairing |
5.0 |
25788263
|
acc1588 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MCF7 |
Tamoxifen |
Impairing |
5.0 |
21170675
|
acc1589 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
TAMR-MCF-7 |
5-Aza |
Associated |
4.0 |
21170675
|
acc1590 |
CIC |
phosphorylation |
Tyr1455 |
mouse |
Glioma |
GL261 |
Dasatinib |
Associated |
4.0 |
32029440
|
acc1591 |
CIC |
phosphorylation |
Tyr1455 |
human |
Glioma |
U87 |
Dasatinib |
Associated |
4.0 |
32029440
|
acc1592 |
CIC |
phosphorylation |
Tyr1455 |
human |
Glioma |
GSC-7-2 |
Dasatinib |
Associated |
4.0 |
32029440
|
acc1593 |
cSrc |
phosphorylation |
Tyr416 |
mouse |
Glioma |
GL261 |
Dasatinib |
Associated |
4.0 |
32029440
|
acc1594 |
cSrc |
phosphorylation |
Tyr416 |
human |
Glioma |
U87 |
Dasatinib |
Associated |
4.0 |
32029440
|
acc1595 |
cSrc |
phosphorylation |
Tyr416 |
human |
Glioma |
GSC-7-2 |
Dasatinib |
Associated |
4.0 |
32029440
|
acc1596 |
CDK2 |
phosphorylation |
unclear |
human |
Breast Cancer |
MDA-MB-435 |
Mevalonate |
Associated |
4.0 |
15155733
|
acc1597 |
p90RSK2 |
phosphorylation |
Thr359 |
human |
Lung Cancer |
H226B |
Kazinol-E |
Associated |
4.0 |
26774343
|
acc1598 |
p90RSK2 |
phosphorylation |
Ser363 |
human |
Lung Cancer |
H226B |
Kazinol-E |
Associated |
4.0 |
26774343
|
acc1599 |
CYLD |
phosphorylation |
Ser418 |
human |
Lymphoma |
HBL-1 |
Ibrutinib |
Associated |
4.0 |
33827598
|
acc1600 |
CYLD |
phosphorylation |
Ser418 |
human |
Lymphoma |
OCI-Ly10 |
Ibrutinib |
Associated |
4.0 |
33827598
|